In module-4 (ME-4), numerous immune-related pathways are significantly enriched, such as PD-L1 expression and PD-1 checkpoint pathway in cancer (ko05235), TNF signaling pathway (ko04668), antigen processing and presentation (ko04612). This evidence concerns the gene CD274 and cancer.